4 Healthcare Stock Stories for Wednesday Investment Wellness

Pfizer (NYSE:PFE): Current price $28.63

In the United Kingdom, the National Institute for Health and Clinical Excellence decided Wednesday that Pfizer’s new lung cancer pill Xalkori costs too much to be worth using on Britain’s state health service. The Institute said that the drug, which works by blocking enzymes that can spur tumour growth, cannot be considered a cost-effective use of National Health Service resources. The agency’s draft guidance on the drug, which costs an applling 4,689 pounds for a 30-day supply is now open for consultation.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

PFE

Ziopharm Oncology (NASDAQ:ZIOP): Current price $1.71

Ziopharm Oncology’s most advanced product, the potential cancer treatment palifosfamide, failed in a late-stage evaluation. The firm also said that it would immediately switch its strategic concentration to synthetic biology programs and commence a restructuring program to summon resources for that. At this time, Ziopharm has no products on the market. Shares had risen as high as $5.95 earlier in March, capping a weeks-long rally after the company said it would go forward with data analysis from the palifosfamide trial. Palifosfamide was being evaluated as a treatment for patients suffering from soft tissue sarcoma, which is a cancer that forms in connective tissue.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

ZIOP

Walgreen Company (NYSE:WAG): Current price $47.25

Walgreen has debuted its second ‘Well Experience’ flagship store in the Empire State Building. Earlier in March, the company launched its first ‘Well Experience’ store in Washington, D.C., and now anticipates the opening of the third store of this kind in Boston in April. Walgreen is optimistic about this strategic move and believes that these select locations will reinforce its brand name in important markets.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

WAG

Baxter International (NYSE:BAX): Current price $71.88

According to The Online Investor, from the most recent look at the underlying components of the S&P 500 ranked by largest market capitalization, Baxter has taken over the number-90 spot from Dow Chemical Company.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

BAX

Don’t Miss: Will Easter Bring Out the Bargain Hunters?